Trial reportMedical devices (Auckland, N.Z.)2026
A Prospective, Multi-Center, Randomized Controlled Study to Evaluate the Efficacy and Safety of Two Absorbable Barbed Sutures in Thyroid Surgery.
Trial report in Medical devices (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to evaluate the safety and effectiveness of two types of absorbable barbed sutures, STRATAFIX Patients and Methods: This study was a multicenter, prospective, evaluator-blinded, three-arm, non-inferiority, randomized controlled design study with a planned enrollment of 501 patients undergoing open thyroid surgery. Subjects were randomized to Spiral PDS Plus group, Spiral MONOCRYL Plus group, or the control group, according to the allocation ratio of 1:1:1. The primary endpoint was the success rate of subjects achieving grade A healing of surgical incisions 5-7 days after surgery. Results: A total of 500 subjects were randomized in this study. The PP analysis was considered the primary analysis, while the FAS analysis was considered supportive. In the PPset, which included 154 subjects in Spiral PDS Plus group, 157 subjects in Spiral MONOCRYL Plus group, and 156 subjects in the control group, the grade A wound healing success rates were 99.4%, 98.7%, and 99.4%, respectively. The differences [Wald 95% CI] in success percentage between the two investigation groups and the control group were -0.01% [-1.79%, 1.77%] and -0.63% [-2.79%, 1.52%], respectively. Both Spiral PDS Plus and Spiral MONOCRYL Plus were found to be non-inferior to control in achieving Grade A healing of surgical incision (0.05 margin, p < 0.0001 for both). Conclusion: This study demonstrated the short-term safety and efficacy outcomes of using STRATAFIX
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.